Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a ...

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. (Manuel Balce Ceneta/AP) Federal health regulators on Friday declined to approve the psychedelic ...